Phase 4 Tuberculosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 65 years old, of any gender
- People who have been diagnosed with pulmonary tuberculosis (TB affecting the lungs) according to a specific Chinese medical standard (WS 288-2017)
- People who have either never received TB treatment before, or have received standard first-line TB medication (HRZE) for less than one week
- People who show signs consistent with a Traditional Chinese Medicine pattern called "Qi and Yin deficiency," which includes at least two of these main symptoms — shortness of breath, tiredness, mental fatigue, or a weak pulse — plus at least one of these additional symptoms: coughing up blood, sweating without exertion, night sweats, poor appetite, bloating, or a red and tender tongue with thin coating
- People who are willing to participate voluntarily, are likely to take medications as directed, and have signed a consent form agreeing to take part
Who may not be able to join:
- People who have received similar Traditional Chinese Medicine treatment in the four weeks before joining the trial
- People whose TB has been found to be drug-resistant or extensively drug-resistant
- People with a known or suspected allergy or serious reaction to the trial drug or any of its ingredients, or who have a history of multiple allergies
- People whose test results have shown non-tuberculosis bacteria growing (on more than two occasions), or who have been diagnosed with a non-tuberculosis bacterial lung infection
- People with recurring TB, or people with a confirmed TB bacterial infection who have already received more than one week of TB treatment
- People who also have autoimmune diseases, cancer, serious blood disorders, epilepsy, or psychiatric conditions
- People with serious heart or brain blood vessel disease, such as severe heart failure, heart attack, or recent serious stroke (confirm with trial site)
- People with uncontrolled high blood pressure (blood pressure at or above 160/100 mmHg at the time of joining)
- People with poorly controlled diabetes
- People with serious liver or kidney disease, or abnormal liver or kidney blood test results above certain levels (confirm with trial site)
- People who have TB affecting parts of the body other than the lungs, such as lymph nodes, bones, kidneys, intestines, the nervous system, or the brain lining
- People who have other lung conditions such as lung cancer, cysts, abscesses, scarring of the lungs, or dust-related lung diseases
- People who are pregnant or breastfeeding
- People living with HIV, or people who test positive for syphilis
- People who have participated in another clinical trial within the past month (confirm with trial site regarding the exact timeframe)
- People with a history of alcohol or drug abuse, or any tendency toward dependence on substances
- People whom the research team considers unsuitable for the trial for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: WENJUAN NIE, DR, Beijing Chest Hospital
Phone: +86 10 89509331
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Primary Outcome: Improvement of symptoms
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.